Catalyst Wire Dossier Catalyst Wire Dossier

Pancrelipase Microtablet Capsules

pancrelipase · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pancrelipase Microtablet Capsules, covering 2010-03-17 to 2010-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency [Phase 3]

See pricing